BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

TAKAFULINS

All Eps Dividend Board Agm Q1 Q2 Q3

TAKAFULINS 30-Oct-2018

Ms. Tahmina Afroz, Mr. Khorshed Alam Khan and Modern Diagnostic Centre Ltd., all are Directors (Public Shareholder Directors) of the Company, have expressed their intention to buy 5,23,000 shares, 2,68,500 shares and 7,07,000 shares of the Company respectively at prevailing market price (in the Block Market) through Stock Exchanges (DSE & CSE) within October 31, 2018.

TAKAFULINS 28-Oct-2018

(Q3 Un-audited): EPS was Tk. 0.44 for July-September, 2018 as against Tk. 0.37 for July-September, 2017; EPS was Tk. 1.02 for January-September, 2018 as against Tk. 1.21 for January-September, 2017. NOCFPS was Tk. 1.49 for January-September, 2018 as against Tk. (0.50) for January-September, 2017. NAV per share was Tk. 16.69 as on September 30, 2018 and Tk. 16.50 as on December 31, 2017.

TAKAFULINS 23-Oct-2018

Dr. Mohammad Osman Ghani, one of the Public Shareholder Directors of the Company, has expressed his intention to sell 14,80,452 shares of the Company at prevailing market price (In the Block Market) through Stock Exchanges (DSE & CSE) within October 31, 2018.

TAKAFULINS 21-Oct-2018

Dr. Mohammad Osman Ghani, one of the Public Shareholder Directors of the Company, has further reported that he has completed his buying of 8,10,000 shares of the Company at prevailing market price through Stock Exchanges as per declaration disseminated on 16.10.2018.

TAKAFULINS 18-Oct-2018

Mr. Md. Mofizuddin, one of the Sponsors of the Company, has expressed his intention to buy 12,567 shares of the Company at prevailing market price (In the Public Market) through Stock Exchange (DSE) within October 31, 2018.

TAKAFULINS 17-Oct-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 25, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2018.

TAKAFULINS 16-Oct-2018

Dr. Mohammad Osman Ghani, one of the Public Shareholder Directors of the Company, has expressed his intention to buy 8,10,000 shares of the Company at prevailing market price (In the Block Market) through Stock Exchanges (DSE & CSE) within October 31, 2018.

TAKAFULINS 01-Aug-2018

(Q2 Un-audited): EPS was Tk. 0.26 for April-June 2018 as against Tk. 0.39 for April-June 2017; EPS was Tk. 0.58 for January-June 2018 as against Tk. 0.83 for January-June 2017. NOCFPS was Tk. 0.80 for January-June 2018 as against Tk. 1.15 for January-June 2017. NAV per share was Tk. 16.25 as on June 30, 2018 and Tk. 16.50 as on December 31, 2017.

TAKAFULINS 19-Jul-2018

Credit Rating Agency of Bangladesh Limited (CRAB) has announced the rating of the Company as "A2" in the long term and "ST-3" in the short term along with a Stable outlook based on audited financial statements of the Company up to December 31, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

TAKAFULINS 18-Jul-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 31, 2018 at 4:00 PM to consider, among others, unaudited financial statements of the Company for the Second Quarter (Q2) period ended on June 30, 2018.

Previous Next page